Tacrolimus alleviates pulmonary fibrosis progression through inhibiting the activation and interaction of ILC2 and monocytes.
Liu B, Jiang Q, Chen R, Zhang H, Xia Q, Shao C, Liu X, Wang M, Shi Y, Zhu J, Zhao R, Jiang H, Gao S, Li X, Zhou H, Yang C, Huang H.
Liu B, et al. Among authors: liu x.
Int Immunopharmacol. 2024 May 10;132:111999. doi: 10.1016/j.intimp.2024.111999. Epub 2024 Apr 5.
Int Immunopharmacol. 2024.
PMID: 38581994
Free article.